| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/23/2003 | CN1413177A Process for preparing fluorine-containing compounds |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1412180A Method for synthesizing 2-chloro-5-methyl pyridina |
| 04/23/2003 | CN1411811A 血液循环改善剂 Blood circulation improving agent |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/23/2003 | CN1106391C Magnolol series compounds and synthesizing process thereof, and medicinal composition using same as active component |
| 04/23/2003 | CN1106371C Liquid crystal compounds having perfluoroether terminal portions |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552188 Unsymmetrical cyclic diamine compound |
| 04/22/2003 | US6552155 Blocked poly(1,4-butanediol)bis(4-aminobenzoate); formulations with polyisocyanates; rapid curing when exposed to water or air humidity; anticorrosive coating, antifouling paint, caulking, sealing, waterproofing |
| 04/22/2003 | US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals |
| 04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
| 04/22/2003 | US6551682 Proper tracking error signals to be adapted to high density information recording and has various characteristics |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 04/17/2003 | WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/17/2003 | WO2003031389A1 Abscisic acid biosynthesis inhibitor |
| 04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | WO2003030905A1 Dihydroorotate dehydrogenase inhibitor |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | WO2003030846A1 Agent for coloring keratin fibers |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003011293A3 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | WO2001053275A3 Substituted aryl ketones |
| 04/17/2003 | US20030073862 Antidiabetic agents, anticancer agents, anticholesterol agents |
| 04/17/2003 | US20030073847 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
| 04/17/2003 | US20030073846 Aminoalcohol derivatives |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073840 Anticancer agents |
| 04/17/2003 | US20030073839 Compounds useful for preparation of Beta-3 adrenoreceptor agonist |
| 04/17/2003 | US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 04/17/2003 | US20030073833 Antiinflammatory agents; anticoagulants |
| 04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
| 04/17/2003 | US20030073731 Alkylation therapy; anticancer agent |
| 04/17/2003 | US20030073725 Naphtalene derivatives and their pharmaceutical use |
| 04/17/2003 | US20030073724 Central nervous system disorders |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents |
| 04/17/2003 | US20030073701 Succinoylamino heterocycles as inhibitors of a beta protein production |
| 04/17/2003 | US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/17/2003 | US20030073669 N-heterocyclic derivatives as NOS inhibitors |
| 04/17/2003 | US20030073640 Novel compositions for the delivery of negatively charged molecules |
| 04/17/2003 | US20030073581 Spraying on plants, environment |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | CA2462689A1 Inhibitor against biosynthesis of abscisic acid |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1302463A1 Medicine comprising dicyanopyridine derivative |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1302461A1 Tnf-alpha production inhibitors |
| 04/16/2003 | EP1301484A2 Capsaicin receptor ligands |
| 04/16/2003 | EP1301483A1 1-aryl-4-alkyl halide-2(1h)-pyridones and their use as herbicides |
| 04/16/2003 | EP1301474A2 Tyrosine derivatives as phosphatase inhibitors |
| 04/16/2003 | EP1301466A2 7-substituted tetracycline compounds |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1163224B1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance |
| 04/16/2003 | EP1144379A4 Low-dusting, flowable aminopyridine products |
| 04/16/2003 | EP1054866B1 Synthesis of 1-(2-sulphoethyl)-pyridinium betaine |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/16/2003 | EP0869945B1 Catechol diethers derivatives useful as pharmaceutical agents |
| 04/16/2003 | EP0787724B1 Novel intermediate for production and process for producing pyridine derivative |
| 04/16/2003 | EP0649414B1 Opioid diarylmethylpiperazines and piperidines |
| 04/16/2003 | CN1411453A Trans olefinic glucokinase activators |
| 04/16/2003 | CN1411451A Method for production of 1,3-disubstituted 2-nitroguanidines |
| 04/16/2003 | CN1411447A Polymorphic crystalline forms of celecoxib |
| 04/16/2003 | CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1411435A Novel use of phenyl hetero alkylamine derivatives |
| 04/16/2003 | CN1411379A Preventives or remedies for arrhythmia |
| 04/16/2003 | CN1410420A Process for preparing alkanosulfuryl pyridine |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/16/2003 | CN1105711C 嘧啶衍生物 Pyrimidine derivatives |
| 04/15/2003 | US6548684 Coupling of nucleophiles, vinyl compounds or CO with water, alcohols or amines to organic compounds |
| 04/15/2003 | US6548672 Complexing 2,6-diiminopyridine with iron, cobalt, manganese, or ruthenium compound |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548549 Fungicides, insecticides, bactericides; applying to plant |
| 04/15/2003 | US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators |
| 04/15/2003 | US6548546 HIV integrase inhibitors |
| 04/15/2003 | US6548523 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 04/15/2003 | US6548522 N-substituted 2,2-diphenylacetamide or N-substituted 2-phenyl-2-pyridinylacetamide |
| 04/15/2003 | US6548519 Pyridoxine and pyridoxal analogues: novel uses |
| 04/15/2003 | US6548514 Inhibitors of p38 kinase/cytokine suppressive binding protein (CSBP)/reactivating kinase (RK); 1-((pyridyl)aminocarbonyl)-3-((hetero)arylaminocarbonyl)benzene derivatives; treating cytokine related diseases and disorders |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | CA2078466C Novel 3-cycloalkyl-propen-2-amide derivatives, tautomers and salts thereof, process for preparing the same and their use as drugs, compositions containing them |
| 04/15/2003 | CA2052433C Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments |
| 04/15/2003 | CA2051504C 1-phenyl-3-aryl-2-propyne-1-ones as calcium uptake inhibitors |
| 04/10/2003 | WO2003029363A1 Water-color ink |
| 04/10/2003 | WO2003029233A1 New sulfonamide derivatives as d3-receptor agonists |
| 04/10/2003 | WO2003029226A1 Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029219A1 Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives |
| 04/10/2003 | WO2003029217A2 Pyridinic sulfonamide derivatives, method of production and use thereof |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029200A2 Compounds useful as reversible inhibitors of cysteine proteases |